A Study of PTC923 in Participants With Phenylketonuria
Trial details
- Registry ID
- NCT05099640
- Phase
- Phase 3
Drug identity checked against registry records
Also recorded as Sephience; Sepiapterin
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| A Study of PTC923 in Participants With PhenylketonuriaNCT05099640 | PTC Therapeutics | Phase 3 | Completed | 2023-04-03Actual |
| A Long-Term Safety Study of PTC923 in Participants With PhenylketonuriaNCT05166161 | PTC Therapeutics | Phase 3 | Completed | 2026-07-21Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |